Market Overview

Akorn Shares Rally Following Increased Price Target

Related AKRX
Morning Market Gainers
Benzinga's Top #PreMarket Gainers
3 Reasons Why Akorn (AKRX) Is a Great Growth Stock - Tale of the Tape (Zacks)

Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.

The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.

Shares are currently up 5.25 percent at $34.99.

Latest Ratings for AKRX

Mar 2015Avondale PartnersInitiates Coverage onOutperform
Mar 2015JefferiesMaintainsBuy
Feb 2015NeedhamDowngradesBuyHold

View More Analyst Ratings for AKRX
View the Latest Analyst Ratings

Posted-In: NeedhamAnalyst Color News Price Target Analyst Ratings


Related Articles (AKRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters